Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew quick-access links were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment'. The revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check18 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4, indicating an administrative update to the ClinicalTrials.gov record. This update does not alter substantive content such as study design or results.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a newer build of the ClinicalTrials.gov record. This change reflects maintenance or metadata updates rather than modifications to study details.SummaryDifference0.0%

- Check46 days agoChange DetectedA new entry for Malmö, Sweden has been added to the study's locations, and the previous Malmo, Sweden entry has been removed.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s displayed site software/version revision was updated from v3.5.2 to v3.5.3. This indicates a technical or platform update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.